|
91 |
Long-term stability of reconstituted incobotulinumtoxinA: how can we reduce costs of botulinum toxin therapy?
Enthalten in Journal of neural transmission Bd. 124, 2.8.2017, Nr. 10, date:10.2017: 1223-1225
|
|
|
|
92 |
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort
Enthalten in Pediatric rheumatology Bd. 22, 21.10.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
93 |
Potency of botulinum toxin drugs: test systems and labelling
Enthalten in Journal of neural transmission Bd. 129, 30.8.2022, Nr. 10, date:10.2022: 1309-1310
|
|
|
|
94 |
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
Enthalten in Journal of neurology Bd. 262, 1.4.2015, Nr. 10, date:10.2015: 2201-2213
|
|
|
|
95 |
Quality of life and costs of spasticity treatment in German stroke patients
Enthalten in Health economics review Bd. 6, 8.7.2016, Nr. 1, date:12.2015: 1-9
|
|
|
|
96 |
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
Enthalten in Health and quality of life outcomes Bd. 18, 4.3.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
97 |
Severe familial paroxysmal exercise-induced dyskinesia
Enthalten in Journal of neurology Bd. 261, 7.8.2014, Nr. 10, date:10.2014: 2009-2015
|
|
|
|
98 |
Strategies for treatment of dystonia
Enthalten in Journal of neural transmission Bd. 123, 14.9.2015, Nr. 3, date:3.2016: 251-258
|
|
|
|
99 |
The natural course of idiopathic cervical dystonia
Enthalten in Journal of neural transmission Bd. 131, 20.1.2024, Nr. 3, date:3.2024: 245-252
|
|
Administration
